Moody's Investors Service affirmed "Aa2" and "Aa2/VMIG 1" ratings on St. Louis- based BJC Health System's fixed rate revenue bonds and variable rate demand bonds, backed by the system's liquidity.
The long-term affirmation is a result of several factors, including the system's improved market position, reputation as a top academic medical center and strong liquidity. The short-term affirmation is a result of proper management of its self-liquidity program and substantial assets to offset potential liabilities.
The outlook is stable reflecting Moody's expectation that BJC's operating performance will improve in fiscal year 2017 and the system will maintain strong liquidity.